Arjun Goyal serves as Executive at Centessa Pharmaceuticals plc, where they oversee executive responsibilities. Since joining the company, Arjun Goyal has executed 4 insider transactions totaling $15.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 2, 2021 involved exercising options for 85,909 shares valued at $0.
Arjun Goyal currently holds 85,909 shares of Centessa Pharmaceuticals plc (CNTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arjun Goyal has been a net buyer of CNTA stock. They have purchased $15.0M and sold $0 worth of shares.
Arjun Goyal's most recent insider trade was on Jun 2, 2021, when they sold 85,909 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $20.00 |
| Discretionary |
| Jun 2, 2021 | CNTA | $0 | Conversion | 3,095,909 | $N/A | Discretionary |
| Jun 2, 2021 | CNTA | $405.0K | Purchase | 20,250 | $20.00 | Discretionary |